Literature DB >> 33477658

Subjective Psychophysical Experiences in the Course of Inflammatory Bowel Disease-A Comparative Analysis Based on the Polish Pediatric Crohn's and Colitis Cohort (POCOCO).

Aleksandra Glapa-Nowak1, Anna Bukowska-Posadzy1,2, Mariusz Szczepanik1, Jarosław Kwiecień3, Anna Szaflarska-Popławska4, Barbara Iwańczak5, Anna Flak-Wancerz6, Łukasz Dembiński7, Marcin Osiecki8, Jarosław Kierkuś8, Tomasz Banasiewicz9, Harald Walach1,10,11, Aleksandra Banaszkiewicz7, Jarosław Walkowiak1.   

Abstract

No gold standard is available to evaluate subjective psychophysical experiences in pediatric inflammatory bowel disease (IBD). We aimed to assess pain, anxiety, and limitations in social activities at diagnosis and the worst flare of the disease in relation to clinical expression, treatment and IBD severity. A total of 376 children completed the survey (Crohn's disease (CD) n = 196; ulcerative colitis (UC) n = 180). The questionnaire included 12 questions regarding pain, anxiety, and social activity, all assessed at recruitment and retrospectively at diagnosis and worst flare using a numeric rating scale. Patients that had ever been treated with systemic glucocorticosteroids scored higher in pain (p < 0.001), anxiety (p = 0.015), and social activity domains (p < 0.016) at worst flare, and the answers correlated with the number of steroid courses (p < 0.0392). The perception of social activity limitations also correlated independently with the number of immunosuppressants (p < 0.0433) and biological agents (p < 0.0494). There was no difference in retrospective perception of pain, anxiety and social activity limitations between CD and UC patients at diagnosis and the worst flare. The level of limitations in social activity correlated with hospitalisations due to relapse, days spent in the hospital, number of relapses, and severe relapses with the strongest association of rho = 0.39 (p = 0.0004). Subjective and retrospective perception of pain, anxiety, and limitations in social activity differs depending on therapy, correlates with treatment modalities, and severity measures such as hospitalisations.

Entities:  

Keywords:  Crohn’s disease; anxiety; pain; social activity; ulcerative colitis

Year:  2021        PMID: 33477658      PMCID: PMC7831504          DOI: 10.3390/ijerph18020784

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  39 in total

Review 1.  Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.

Authors:  J Langhorst; H Wulfert; R Lauche; P Klose; H Cramer; G J Dobos; J Korzenik
Journal:  J Crohns Colitis       Date:  2014-11-28       Impact factor: 9.071

2.  The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model.

Authors:  Jennifer Devlen; Kathleen Beusterien; Linnette Yen; Awais Ahmed; Adam S Cheifetz; Alan C Moss
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

3.  The Short Health Scale: a valid measure of subjective health in ulcerative colitis.

Authors:  Henrik Hjortswang; Gunnar Järnerot; Bengt Curman; Hanna Sandberg-Gertzén; Curt Tysk; Björn Blomberg; Sven Almer; Magnus Ström
Journal:  Scand J Gastroenterol       Date:  2006-10       Impact factor: 2.423

4.  Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample.

Authors:  Lesley Dibley; Christine Norton
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

5.  Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population.

Authors:  Winfried Häuser; Karl-Heinz Janke; Bodo Klump; Andreas Hinz
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

6.  Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis.

Authors:  H Cramer; M Schäfer; M Schöls; J Köcke; S Elsenbruch; R Lauche; H Engler; G Dobos; J Langhorst
Journal:  Aliment Pharmacol Ther       Date:  2017-04-05       Impact factor: 8.171

Review 7.  Health status in inflammatory bowel disease. Biological and behavioral considerations.

Authors:  J W Garrett; D A Drossman
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

8.  Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions.

Authors:  Kate R Muller; Ruth Prosser; Peter Bampton; Reme Mountifield; Jane M Andrews
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

Review 9.  Inflammatory bowel disease and anxiety: links, risks, and challenges faced.

Authors:  Ayman S Bannaga; Christian P Selinger
Journal:  Clin Exp Gastroenterol       Date:  2015-03-23

10.  Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study.

Authors:  Kookhwan Choi; Jaeyoung Chun; Kyungdo Han; Seona Park; Hosim Soh; Jihye Kim; Jooyoung Lee; Hyun Jung Lee; Jong Pil Im; Joo Sung Kim
Journal:  J Clin Med       Date:  2019-05-10       Impact factor: 4.241

View more
  2 in total

1.  C-Reactive Protein/Albumin Ratio at Diagnosis of Pediatric Inflammatory Bowel Disease: A Retrospective Multi-Center Study.

Authors:  Aleksandra Glapa-Nowak; Mariusz Szczepanik; Aleksandra Banaszkiewicz; Jarosław Kwiecień; Anna Szaflarska-Popławska; Urszula Grzybowska-Chlebowczyk; Marcin Osiecki; Jarosław Kierkuś; Marcin Dziekiewicz; Jarosław Walkowiak
Journal:  Med Sci Monit       Date:  2022-09-14

2.  The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease-A Cross-Sectional Pilot Study.

Authors:  Łukasz Mokros; Danuta Domżał-Magrowska; Tadeusz Pietras; Kasper Sipowicz; Renata Talar-Wojnarowska
Journal:  Life (Basel)       Date:  2021-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.